Rutgers-led immune system research may also help reveal new asthma clues.

The custom technologies arm of Molecular Devices, a leader in bioanalytical systems for drug discovery, life science research, and bioassay development, has partnered with the Discovery Technologies team at the Roche Innovation Center Basel of Pharma Research and Early Development (pRED) to develop a high-throughput detection system for drug discovery screens employing Roche’s proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF®) assays. The pRED screening teams in Basel and Shanghai are now installing the custom-developed Nano-TRF® cartridge in their existing Molecular Devices SpectraMax® Paradigm® multimode microplate readers and will receive on-demand delivery of new cartridges and continuing global technical support.

Salk research indicates a potential mechanism for cancer cells' adaptability.

The pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in?

Biomedical engineering researchers have developed a drug delivery system consisting of nanoscale “cocoons” made of DNA that target cancer cells and trick the cells into absorbing the cocoon before unleashing anticancer drugs. The work was done by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.

A Kansas State University professor is researching ways to keep animals and humans safe from tick-borne diseases.

Scientists at Benaroya Research Institute at Virginia Mason (BRI) recently received a $2.2 million grant from the National Institutes of Health to find a unique biomarker that initiates and drives allergies. This grant expands on previous discoveries that led to the isolation of a type of white blood cells that show up only in people with allergic disease. 

A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for clinicians and law enforcement.

Problem: In recent years, cell biology has included more emphasis on the study of rapid movement inside live cells: its dynamics, mechanisms, electrochemical signaling and protein transport. To capture these events while avoiding image artifacts, frame rates must be high enough to accurately sample these cellular phenomena. Depending on the event, these rates can range from 20 to several thousand frames per second with exposure times well below 100ms.

Salk scientists find that a vitamin D-derivative makes tumors vulnerable to chemotherapy.

This is the inescapable conclusion of Michael Kinch’s adventures in data mining

Findings from two newly published papers may help provide a design for new anticancer tactics.